某大学医院类风湿关节炎治疗的横断面研究。
Cross-sectional study of rheumatoid arthritis treatment in a university hospital.
作者信息
Friesen W T, Hekster Y A, van de Putte L B, Gribnau F W
出版信息
Ann Rheum Dis. 1985 Jun;44(6):372-8. doi: 10.1136/ard.44.6.372.
Drug prescribing patterns for the management of inpatients and outpatients with rheumatoid arthritis (RA) were investigated. The population of patients resembled published epidemiological descriptions of RA patients with respect to age and sex distribution. Multiple drug therapy was common in the treatment of both hospitalised and clinic patients. 90% of all patients with RA received non-steroidal anti-inflammatory drug (NSAID) therapy, indomethacin and naproxen being the two most frequently prescribed NSAIDs for both in- and outpatients. The vast majority of inpatients (85%) and outpatients (79%) received slow-acting antirheumatic drug (SAARD) treatment. 13% of hospitalised patients received H2-antagonist drugs in addition to their NSAIDs. A high proportion of inpatients (46%) received oral corticosteroids in the management of their rheumatoid arthritis, while only 15% of clinic patients were prescribed corticosteroids.
对类风湿性关节炎（RA）住院患者和门诊患者的药物处方模式进行了调查。患者群体在年龄和性别分布方面与已发表的RA患者流行病学描述相似。在住院患者和门诊患者的治疗中，联合用药很常见。所有RA患者中有90%接受了非甾体抗炎药（NSAID）治疗，吲哚美辛和萘普生是住院患者和门诊患者中最常处方的两种NSAID。绝大多数住院患者（85%）和门诊患者（79%）接受了慢作用抗风湿药（SAARD）治疗。13%的住院患者除NSAID外还接受了H2拮抗剂药物治疗。高比例的住院患者（46%）在类风湿性关节炎治疗中接受了口服皮质类固醇，而只有15%的门诊患者被处方了皮质类固醇。
Zotero 插件